Search results
Results from the WOW.Com Content Network
Bayer's executive board won a clear vote of confidence from shareholders on Tuesday, following a rebuke last year over the handling of lawsuits related to a weedkiller. Of the valid votes cast at ...
Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room ...
Bayer shareholder Union Investment on Monday came out in support of the drugmaker's chief executive serving out his full term after the CEO came under renewed pressure over the company's performance.
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2]Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.
FRANKFURT (Reuters) -Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare and agriculture group, defying a ...
Losses for Bayer investors reach tens of billions of Euros just two years after the acquisition. His position as CEO of Bayer was renewed in 2020 until 2024 before the general meeting of shareholders in 2021. [10] [11] [12] By 2023, Bayer investor DekaBank called for Baumann to be replaced ahead of his scheduled departure. [13]
Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker's $63 billion takeover of seed maker Monsanto. Several large ...
Bayer AG was founded as a dyestuffs factory in 1863 in Barmen ... The 10 largest shareholder of Bayer AG in early 2024 were: [154] Shareholder name Percentage